NewsPronto

 
Men's Weekly

.

ACN Newswire

Read more press releases from ACN Newswire here

China Biotech Services (8037.HK) and National Institute for Viral Disease Control and Prevention (NIVDC) to develop Genetically Engineered Recombinant Vaccine for COVID-19

  • Written by ACN Newswire

image

HONG KONG, Oct 5, 2020 - (ACN Newswire) - China Biotech Services Holdings (CBSH; 8037.HK) announced that its wholly-owned subsidiary Shenzhen Genius Biotech Services Co., Ltd. (Shenzhen Genius) and the National Institute for Viral Disease Control and Prevention (NIVDC) of the Chinese Center for Disease Control and Prevention (China CDC) have...

Read more: China Biotech Services (8037.HK) and National Institute for Viral Disease Control and Prevention...